Dr. Cooperstone is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
500 Arcola Road
Collegeville, PA 19426Phone+1 484-865-5124
Education & Training
- McGill University Faculty of MedicineClass of 1988
Certifications & Licensure
- PA State Medical License 1991 - 2024
- GA State Medical License 1994 - 1999
Publications & Presentations
PubMed
- 69 citationsSirolimus for rescue and primary immunosuppression in transplanted children receiving tacrolimusRakesh Sindhi, Steven A. Webber, Raman Venkataramanan, William McGhee, Susan Phillips
Transplantation. 2001-09-15 - 3 citationsIn vitro and in vivo expression of a nephritogenic Ig heavy chain determinant: pathogenic autoreactivity requires permissive light chains.Brenda G. Cooperstone, Mohammed M Rahman, Earl H. Rudolph, Mary H. Foster
Immunology and Cell Biology. 2001-06-01 - 3 citationsAnti-Idiotypic Monoclonal Ig Specific for an Anti-Laminin Ig Heavy Chain Transgene Variable RegionMary H. Foster, Brenda G. Cooperstone, Howard Y. Chen
Hybridoma. 1998-08-01
Press Mentions
- Pfizer’s VYNDAQEL®/VYNDAMAX® Reduced the Risk of All-Cause Mortality by 41% Among Patients with Transthyretin Amyloid Cardiomyopathy, Five-Year Follow-up Data DemonstrateDecember 20th, 2021
- EMA Adopts a Positive CHMP Opinion for Pfizer’s and OPKO’s Somatrogon, a Long-Acting Treatment for Pediatric Growth Hormone DeficiencyDecember 17th, 2021
- Health Canada Approves NGENLA (Somatrogon) Injection for Pediatric Growth Hormone DeficiencyOctober 29th, 2021
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: